2011 NLA Scientific Sessions Highlights
Clinical Trial Updates Impacting Your Practice

Philip J. Barter, MD, PhD
Prof. Barter reviews some recent trials with fibrates, statins, and niacin that he believes should have an impact on current clinical practice.
Tags:
What Do Simple Genetics Tell Us About Complex Diseases?

Jonathan C. Cohen, PhD
In the Keynote Presentation of the 7th Annual Scientific Sessions, Dr Cohen reviewed what "simple" genetics can tell us about coronary heart disease (CHD).
Tags:
The Impact of Prescription Switching on LDL-C Goal Attainment

JoAnne M. Foody, MD, FACC, FAHA
Dr Foody focused on the unintended consequences of formulary changes and the potentially harmful effects, with respect to providing evidence-based care or meeting therapeutic goals. She noted that in the United Kingdom (UK), forced switching of high-dose to low-dose statin resulted in higher rates of death, cardiac death, and non-cardiac death in individuals switched to the lower dose.
Tags:
Common Etiologies of Hypertriglyceridemia

Henry N. Ginsberg, MD
At least 95% of people with type-2 diabetes are insulin resistant. In the adipose tissue, insulin-resistant cells release fatty acids, increasing fatty acid flux to the liver resulting in transformation of the excess into triglycerides (TG)
Tags: